Transjugular intrahepatic portosystemic shunts through hepatic neoplasms

Journal of Vascular and Interventional Radiology

Volumn 14, Issue 4, 2003, Pages 501-507

  Wallace, Michael ^a   Swaim, Mark ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER TUMOR; PHLEBOGRAPHY; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0037386463     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000064846.87207.AB     Document Type: Article

References (16)

1. Haskal ZJ, Martin L, Cardella JF, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. SCVIR Standards of Practice Committee. J Vasc Interv Radiol 2001; 12:131-136.
2. Barton RE, Rosch J, Saxon RR, Lakin PC, Petersen BD, Keller FS. TIPS: short and long-term results: a survey of 1,750 patients. Semin Interv Radiol 1995; 12:364.
3. Blum U, Rossle M, Haag K, et al. Budd-Chiari syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt. Radiology 1995; 197:805-811.
4. Walser EM, NcNees SW, DeLa Pena O, et al. Portal venous thrombosis: percutaneous therapy and outcome. J Vasc Interv Radiol 1998; 9(1 Pt 1):119-127.
5. Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med 1992; 117:215-220.
6. Shin ES, Darcy MD. Transjugular intrahepatic portosystemic shunt placement in the setting of polycystic liver disease: questioning the contraindication. J Vasc Interv Radiol 2001; 12:1099-1102.
7. Zuckerman DA, Darcy MD, Bocchini TP, Hildebolt CF. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors. AJR Am J Roentgenol 1997; 169:1727-1731.
8. LaBerge JM, Ring EJ, Gordon RL, et al. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology 1993; 187:413-420.
9. Hidajat N, Vogl T, Stobbe H, et al. Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation center. Acta Radiol 2000; 41:474-478.
10. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in pafients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871.
11. Jalan R, Lui HF, Redhead DN, Hayes PC. TIPSS 10 years on. Gut 2000; 46:578-581.
12. Coldwell DM, Ring EJ, Rees CR, et al. Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension. Radiology 1995; 196: 335-340.
13. Encarnacion CE, Palmaz JC, Rivera FJ, et al. Transjugular intrahepatic portosystemic shunt placement for variceal bleeding: predictors of mortality. J Vasc Interv Radiol 1995; 6:687-694.
14. Saxon RS, Ross PL, Mendel-Hartvig J, et al. Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms. Radiology 1998; 207:683-693.
15. Saxon RR, Mendel-Hartvig J, Corless CL, et al. Bile duct injury as a major cause of stenosis and occlusion in trans jugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine. J Vasc Interv Radiol 1996; 7:487-497.
16. Otal P, Smayra T, Bureau C, et al. Preliminary results of a new expanded-polytetrafluoroethylene-covered stentgraft for transjugular intrahepatic portosystemic shunt procedures. AJR Am J Roentgenol 2002; 178:141-147.